Scolaris Content Display Scolaris Content Display

Morfina oral para el dolor por cáncer

Appendices

Appendix 1. MEDLINE search strategy

The subject search used a combination of controlled vocabulary and free text terms based on the following search strategy for searching MEDLINE.

#1 MORPHINE*:ME
#2 MORPHINE
#3 DELAYED‐ACTION‐PREPARATIONS:ME
#4 TABLETS‐ENTERIC‐COATED:ME
#5 ((#1 or #2) and (#3 or #4))
#6 (MORPHINE NEAR "SUSTAINED RELEASE")
#7 (MORPHINE NEAR SUSTAINED‐RELEASE)
#8 (MORPHINE NEAR "CONTROLLED RELEASE")
#9 (MORPHINE NEAR CONTROLLED‐RELEASE)
#10 (MORPHINE NEAR "IMMEDIATE RELEASE")
#11 (MORPHINE NEAR IMMEDIATE‐RELEASE)
#12 (MORPHINE NEAR "MODIFIED RELEASE")
#13 (MORPHINE NEAR MODIFIED‐RELEASE)
#14 (MORPHINE NEAR "EXTENDED RELEASE")
#15 (MORPHINE NEAR EXTENDED‐RELEASE)
#16 (MORPHINE and ((((((MST or SRM) or IRM) or MSS) or MSC) or MOS) or MHIR))
#17 (MORPHINE and CONTIN)
#18 (MORPHINE near (ORAL next SOLUTION))
#19 KADIAN
#20 KAPANOL
#21 (((((((((((((((((#1 or #2) or #5) or #6) or #7) or #8) or #9) or #10) or #11) or #12) or #13) or #14) or #15) or #16) or #17) or #18) or #19) or #20)
#22 ADMINISTRATION‐ORAL:ME
#23 (ORAL‐ADMINISTRATION or (ORAL next ADMINISTRATION))
#24 (ORAL next ROUTE)
#25 (ORAL near MORPHINE)
#26 ORAL‐MORPHINE
#27 ((((#22 or #23) or #24) or #25) or #26)
#28 (#21 and #27)
#29 NEOPLASMS*:ME
#30 CANCER*
#31 NEOPLASM*
#32 ((#29 or #30) or #31)
#33 PAIN*:ME
#34 PAIN‐MEASUREMENT:ME
#35 PAIN‐THRESHOLD:ME
#36 PAIN*
#37 (((#33 or #34) or #35) or #36)
#38 ((#28 and #32) and #37)

Appendix 2. EMBASE search strategy

#1 morphine/

#2 exp delayed release formulation/

#3 enteric coated tablet/

#4 2 or 3

#5 2 AND 4

#6 (MST or SRM or IRM or MSS).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

#7 (MSC or MOS or MHIR).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

#8 (MORPHINE and CONTIN).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

#9 (KADIAN or KAPENOL).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

#10 5 or 6 or 7 or 8 or 9

#11 exp oral drug administration/

#12 10 AND 11

#13 CANCER.mp. or neoplasm/

#14 pain/

#15 pain assessment/

#16 14 OR 15

#17 12 AND 13 AND 16

Appendix 3. CENTRAL search strategy

#1 "morphine":ti,ab,kw (Word variations have been searched)

#2 Neoplasms

#3 Pain OR pain assessment

#4 #1 AND #2 AND #3

Study flow diagram.

Figuras y tablas -
Figure 1

Study flow diagram.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Figuras y tablas -
Figure 2

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Figuras y tablas -
Figure 3

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Percentage of participants with oral morphine reporting no worse than mild pain. The size of the symbol is proportional to the size of the sample

Figuras y tablas -
Figure 4

Percentage of participants with oral morphine reporting no worse than mild pain. The size of the symbol is proportional to the size of the sample

Percentage of participants with oral morphine reporting an outcome equivalent to treatment success. The size of the symbol is proportional to the size of the sample

Figuras y tablas -
Figure 5

Percentage of participants with oral morphine reporting an outcome equivalent to treatment success. The size of the symbol is proportional to the size of the sample